Related Experiment Videos
Therapy of amyloid diseases
1Max-Planck-Institute of Biochemistry, Munich, Germany.
Renal Failure
|January 1, 1993
Summary
Amyloidosis comprises diverse diseases, necessitating protein identification for accurate diagnosis and tailored therapy. This review distinguishes amyloid syndromes and explores successful treatment strategies for amyloid deposits.
Area of Science:
- Biochemistry
- Pathology
- Medical Science
Background:
- Amyloid deposition in the body causes severe clinical symptoms and syndromes, collectively known as amyloidosis.
- Amyloidosis is not a single disease but a diverse group of conditions.
- Different amyloid diseases are distinguished by the specific protein from which the amyloid is derived.
Purpose of the Study:
- To definitively distinguish between different amyloid syndromes based on their underlying protein.
- To review successful therapeutic strategies for various amyloid deposits and amyloidoses.
- To highlight the necessity of type-specific amyloid therapy due to the pathogenetically diverse nature of these syndromes.
Main Methods:
- Protein identification to differentiate amyloid types.
- Review of existing literature on amyloidosis pathogenesis and treatment.
- Analysis of successful therapeutic interventions for specific amyloid diseases.
Main Results:
- Established methods for distinguishing various amyloidosis types based on protein composition.
- Identified successful therapeutic approaches for certain amyloid syndromes.
- Highlighted the limitations in current therapies for most amyloidosis cases.
Conclusions:
- Accurate diagnosis through protein identification is crucial for effective amyloidosis management.
- Type-specific therapy is mandatory for treating diverse amyloid diseases.
- Further research is needed to develop efficient therapies for the majority of amyloid syndromes.